华熙生物: 华熙生物2024年年度权益分派实施公告

Core Viewpoint - The company has announced a differentiated dividend distribution plan, with a cash dividend of RMB 0.11 per share (tax included) for the 2024 fiscal year, approved at the annual shareholders' meeting on June 11, 2025 [1][2]. Dividend Distribution Plan - The total share capital, excluding shares in the company's repurchase account, is 481,678,242 shares, with 3,315,538 shares in the repurchase account, resulting in 478,362,704 shares eligible for the dividend distribution [2]. - The cash dividend distribution will not involve capital reserve conversion to share capital or the issuance of bonus shares [1][2]. - The reference price for the ex-dividend (ex-rights) calculation is determined by the formula: (previous closing price - cash dividend) / (1 + change in circulating shares ratio) [2]. Tax Implications - For individual shareholders and securities investment funds, dividends are subject to different tax treatments based on the holding period. If held for over one year, dividends are exempt from individual income tax. For holdings of one year or less, tax will be calculated upon the sale of shares [3][4]. - Qualified Foreign Institutional Investors (QFIIs) will have a 10% corporate income tax withheld on dividends, resulting in a net cash dividend of RMB 0.099 per share [4]. - For Hong Kong investors holding shares through the "Shanghai-Hong Kong Stock Connect," a 10% withholding tax will also apply, leading to a net cash dividend of RMB 0.099 per share [4]. Implementation Details - Cash dividends will be distributed through the China Securities Depository and Clearing Corporation Limited Shanghai Branch, with specific arrangements for different types of shareholders [3][5]. - Shareholders who have not completed designated trading will have their dividends held by the clearing company until the trading is completed [3].